American Regent Animal Health has issued a nationwide recall of two lots of Adequan Canine injections and two lots of Adequan i.m. equine injections after testing of internally retained samples turned up visible glass fiber material, the FDA announced July 31.
Which lots are affected
- Adequan Canine — Lot 3369
- Adequan Canine — Lot 25011
- Adequan i.m. (equine) — Lot 24416
- Adequan i.m. (equine) — Lot 25265P
The products were distributed nationwide to online pharmacies, distributors, wholesalers and veterinarians between May 2024 and January 2026. Adequan is a widely used polysulfated glycosaminoglycan injection prescribed to treat joint dysfunction in dogs and non-infectious degenerative joint disease in horses.





